BlackRock, Inc. 13D and 13G filings for Cartesian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-05-09 3:23 pm Sale |
2022-04-30 | 13G | Cartesian Therapeutics, Inc. RNAC |
BlackRock Inc. BLK |
226,876 4.500% |
-4,853 (-2.09%) |
Filing |
| 2022-02-02 7:11 pm Purchase |
2021-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC |
BlackRock Inc. BLK |
231,729 6.000% |
49,252 (+26.99%) |
Filing |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Cartesian Therapeutics, Inc. RNAC |
BlackRock Inc. BLK |
182,477 5.100% |
182,477 (New Position) |
Filing |